Ποια είναι η τιμή για PT Tempo Scan Pacific Tbk (TSPC)

Η τιμή για PT Tempo Scan Pacific Tbk (TSPC) είναι $0.16403186

Ποια είναι η κεφαλαιοποίηση αγοράς για PT Tempo Scan Pacific Tbk (TSPC)

Η κεφαλαιοποίηση αγοράς για PT Tempo Scan Pacific Tbk (TSPC) είναι $739.76M

PT Tempo Scan Pacific Tbk (TSPC) Τιμή και Κεφαλαιοποίηση Αγοράς

PT Tempo Scan Pacific Tbk, an Indonesian company headquartered in Jakarta with an international presence, operates primarily across three core business segments: pharmaceuticals, consumer products and cosmetics, and distribution services. Its activities encompass the trading of pharmaceutical and medical devices, alongside the manufacturing of diverse goods such as soaps, herbal products, powdered milk, food and beverages, and plastic packaging. The company also produces and markets a variety of consumer goods, cosmetic lines, and household items. Products are sold under an extensive portfolio of brands, including Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, MY BABY, MY BABY Kids, Pure Baby, S.O.S, Total Care, and ULTIMA II. Beyond these, PT Tempo Scan Pacific Tbk offers a range of supplementary services, including property construction and leasing, warehousing and freight forwarding, advertising and promotion, research and development, and information technology and communication network systems. It also manages procurement, distribution, and marketing functions. Established in 1970, the company was formerly known as PT Scanchemie and functions as a subsidiary of PT Bogamulia Nagadi.

Η τιμή για TSPC	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$1,167.19 $739.76M	NVDA	$5.264T	+711,462.88%
$1,042.44 $739.76M	AAPL	$4.701T	+635,412.44%
$926.23 $739.76M	GOOG	$4.177T	+564,565.52%
$846.46 $739.76M	MSFT	$3.817T	+515,931.38%
$635.57 $739.76M	AMZN	$2.866T	+387,367.73%

Η τιμή για TSPC

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$1,167.19 $739.76M